Answers are grounded in this paper and cite their sources.
Volumetry of enhancing pannus can be used as a marker for disease activity in synovial proliferative disorders such as RA. Enhancing pannus quantified by manual outlining as well as semiquantitative visual assessment of synovitis is too time-consuming to be justified in busy clinical practice. Our study showed great potential for automated quantitative segmentation and quantification of enhancing pannus, which would allow for accurate estimation of disease aggressiveness and thus prompt early therapeutic intervention for patients and assessment of treatment efficacy without increasing the burden on physicians.
No takes yet. Share an insight, caveat, or question.
Fang et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: